We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTGP icon
2026
WisdomTree Mortgage Plus Bond Fund
MTGP
$74.4M
$493K ﹤0.01%
+11,328
New +$492K
FTXH icon
2027
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$965M
$491K ﹤0.01%
+17,915
New +$477K
NFTY icon
2028
First Trust India Nifty 50 Equal Weight ETF
NFTY
$118M
$490K ﹤0.01%
+11,221
New +$503K
FTSD icon
2029
Franklin Short Duration US Government ETF
FTSD
$309M
$489K ﹤0.01%
5,463
+586
+12% +$52.4K
S icon
2030
SentinelOne
S
$8.17B
$488K ﹤0.01%
33,476
-1,895
-5% -$35.1K
SLRC icon
2031
SLR Investment Corp
SLRC
$711M
$488K ﹤0.01%
35,080
-8,382
-19% -$116K
TEVA icon
2032
Teva Pharmaceuticals
TEVA
$42.6B
$488K ﹤0.01%
53,467
+4,959
+10% +$43.3K
BEP icon
2033
Brookfield Renewable
BEP
$10.6B
$487K ﹤0.01%
19,228
+2,360
+14% +$67.4K
TPZ
2034
Tortoise Electrification Infrastructure ETF
TPZ
$127M
$487K ﹤0.01%
38,169
-5,337
-12% -$70.8K
CROX icon
2035
Crocs
CROX
$6.36B
$485K ﹤0.01%
4,469
-1,886
-30% -$167K
GEMD icon
2036
Goldman Sachs Access Emerging Markets USD Bond ETF
GEMD
$37.6M
$485K ﹤0.01%
+12,156
New +$474K
PNR icon
2037
Pentair
PNR
$10.7B
$485K ﹤0.01%
10,777
+2,343
+28% +$102K
PSFD icon
2038
Pacer Swan SOS Flex January ETF
PSFD
$60.1M
$485K ﹤0.01%
20,310
-1,704
-8% -$39.2K
QHY
2039
WisdomTree U.S. High Yield Corporate Bond Fund
QHY
$244M
$484K ﹤0.01%
+11,024
New +$488K
HTAB icon
2040
Hartford Schroders Tax-Aware Bond ETF
HTAB
$291M
$483K ﹤0.01%
25,336
+11,291
+80% +$212K
CC icon
2041
Chemours
CC
$2.3B
$482K ﹤0.01%
15,745
-667
-4% -$20K
HALO icon
2042
Halozyme
HALO
$11.4B
$482K ﹤0.01%
8,475
-505
-6% -$25.9K
KJAN icon
2043
Innovator US Small Cap Power Buffer ETF January
KJAN
$328M
$482K ﹤0.01%
16,112
-6,480
-29% -$194K
ULH icon
2044
Universal Logistics Holdings
ULH
$518M
$482K ﹤0.01%
14,418
+4,766
+49% +$167K
DMLP icon
2045
Dorchester Minerals
DMLP
$1.35B
$480K ﹤0.01%
16,029
+4,040
+34% +$116K
POWA icon
2046
Invesco Bloomberg Pricing Power ETF
POWA
$184M
$480K ﹤0.01%
7,224
-560
-7% -$37K
CALM icon
2047
Cal-Maine
CALM
$3.87B
$479K ﹤0.01%
8,806
+2,569
+41% +$149K
KBWP icon
2048
Invesco KBW Property & Casualty Insurance ETF
KBWP
$267M
$479K ﹤0.01%
5,568
+1,344
+32% +$112K
VCEB icon
2049
Vanguard ESG US Corporate Bond ETF
VCEB
$1.15B
$479K ﹤0.01%
7,903
+91
+1% +$5.48K
JRI icon
2050
Nuveen Real Asset Income & Growth Fund
JRI
$348M
$478K ﹤0.01%
40,835
+907
+2% +$10.5K

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.